Septic encephalopathy and septic encephalitis‬‬

References

• Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303–1310.
   PubMed Web of Science ®Google Scholar
• Siddiqi N, House AO, Holmes JD. Occurrence and outcome of delirium in medical in-patients: a systematic literature review. Age Ageing. 2006;35(4):350–364.
   PubMed Web of Science ®Google Scholar
• Ebersoldt M, Sharshar T, Annane D. Sepsis-associated delirium. Intensive Care Med. 2007;33(6):941–950.
   PubMed Web of Science ®Google Scholar
• Gofton TE, Young GB. Sepsis-associated encephalopathy. Nat Rev Neurol. 2012;8(10):557–566.
   PubMed Web of Science ®Google Scholar
• Warren HS. Strategies for the treatment of sepsis. New Engl J Med. 1997;336(13):952–953.
   PubMed Web of Science ®Google Scholar
• Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. New Engl J Med. 2003;348(2):138–150.
   PubMed Web of Science ®Google Scholar
• Sprung CL, Peduzzi PN, Shatney CH, et al. Impact of encephalopathy on mortality in the sepsis syndrome. The veterans administration systemic sepsis cooperative study group. Crit Care Med. 1990;18(8):801–806.
   PubMed Web of Science ®Google Scholar
• Iwashyna TJ, Ely EW, Smith DM, et al. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010;304(16):1787–1794.
   PubMed Web of Science ®Google Scholar
• Widmann CN, Heneka MT. Long-term cerebral consequences of sepsis. Lancet Neurol. 2014;13(6):630–636.
   PubMed Web of Science ®Google Scholar
• Mazeraud A, Pascal Q, Verdonk F, et al. Neuroanatomy and physiology of brain dysfunction in sepsis. Clin Chest Med. 2016;37(2):333–345.
   PubMed Web of Science ®Google Scholar
• Salluh JI, Wang H, Schneider EB, et al. Outcome of delirium in critically ill patients: systematic review and meta-analysis. BMJ. 2015;350:h2538.
   PubMed Web of Science ®Google Scholar
• Brummel NE, Jackson JC, Pandharipande PP, et al. Delirium in the ICU and subsequent long-term disability among survivors of mechanical ventilation. Crit Care Med. 2014;42(2):369–377.
   PubMed Web of Science ®Google Scholar
• Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263–306.
   PubMed Web of Science ®Google Scholar
• Ely EW, Margolin R, Francis J, et al. Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med. 2001;29(7):1370–1379.
   PubMed Web of Science ®Google Scholar
• European Delirium Association; American Delirium Society. The DSM-5 criteria, level of arousal and delirium diagnosis: inclusiveness is safer. BMC Med. 2014;12:141.
   PubMed Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2013;315(8):801–810.
   Web of Science ®Google Scholar
• Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):762–774.
   PubMed Web of Science ®Google Scholar
• Polito A, Eischwald F, Maho AL, et al. Pattern of brain injury in the acute setting of human septic shock. Crit Care. 2013;17(5):R204.
   Google Scholar
• Siami S, Annane D, Sharshar T. The encephalopathy in sepsis. Crit Care Clin. 2008;24(1):67–82.
   PubMed Web of Science ®Google Scholar
• Hosokawa K, Gaspard N, Su F, et al. Clinical neurophysiological assessment of sepsis-associated brain dysfunction: a systematic review. Crit Care. 2014;18(6):674.
   PubMed Web of Science ®Google Scholar
• Berisavac II, Padjen VV, Ercegovac MD, et al. Focal epileptic seizures, electroencephalography and outcome of sepsis associated encephalopathy-a pilot study. Clin Neurol Neurosurg. 2016;148:60–66.
   PubMed Web of Science ®Google Scholar
• Azabou E, Magalhaes E, Braconnier A, et al. Early standard electroencephalogram abnormalities predict mortality in septic intensive care unit patients. PLoS One. 2015;10(10):e0139969.
   PubMed Web of Science ®Google Scholar
• Gutierrez EG, Banks WA, Kastin AJ. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J Neuroimmunol. 1993;47(2):169–176.
   PubMed Web of Science ®Google Scholar
• Banks WA, Kastin AJ, Durham DA. Bidirectional transport of interleukin-1 alpha across the blood-brain barrier. Brain Res Bull. 1989;23(6):433–437.
   PubMed Web of Science ®Google Scholar
• Rothwell NJ, Luheshi G. Pharmacology of interleukin-1 actions in the brain. Adv Pharmacol. 1994;25:1–20.
   PubMedGoogle Scholar
• Pan W, Kastin AJ. TNF-alpha transport across the blood-brain barrier is abolished in receptor knockout mice. Exp Neurol. 2002;174(2):193–200.
   PubMed Web of Science ®Google Scholar
• Akrout N, Sharshar T, Annane D. Mechanisms of brain signaling during sepsis. Curr Neuropharmacol. 2009;7(4):296–301.
   PubMed Web of Science ®Google Scholar
• Banks WA, Kastin AJ, Gutierrez EG. Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci Lett. 1994;179(1–2):53–56.
   PubMed Web of Science ®Google Scholar
• Sun D, Lytle C, O’Donnell M. IL-6 secreted by astroglial cells regulates Na-K-Cl cotransport in brain microvessel endothelial cells. Am J Physiol. 1997;272(6pt1):C1829–C1835.
   Google Scholar
• Miyata S. New aspects in fenestrated capillary and tissue dynamics in the sensory circumventricular organs of adult brains. Front Neurosci. 2015;9:390.
   PubMed Web of Science ®Google Scholar
• Banks WA, Robinson SM. Minimal penetration of lipopolysaccharide across the murine blood-brain barrier. Brain Behav Immun. 2010;24(1):102–109.
   PubMed Web of Science ®Google Scholar
• Perry VH, Newman TA, Cunningham C. The impact of systemic infection on the progression of neurodegenerative disease. Nat Rev Neurosci. 2003;4(2):103–112.
   PubMed Web of Science ®Google Scholar
• Mayhan WG. Effect of lipopolysaccharide on the permeability and reactivity of the cerebral microcirculation: role of inducible nitric oxide synthase. Brain Res. 1998;792(2):353–357.
   PubMed Web of Science ®Google Scholar
• Michels M, Danielski LG, Dal-Pizzol F, et al. Neuroinflammation: microglial activation during sepsis. Curr Neurovasc Res. 2014;11(3):262–270.
   PubMed Web of Science ®Google Scholar
• Lu CX, Qiu T, Tong HS, et al. Peripheral T-lymphocyte and natural killer cell population imbalance is associated with septic encephalopathy in patients with severe sepsis. Exp Ther Med. 2016;11(3):1077–1084.
   PubMed Web of Science ®Google Scholar
• Schramm P, Klein KU, Falkenberg L, et al. Impaired cerebrovascular autoregulation in patients with severe sepsis and sepsis-associated delirium. Crit Care. 2012;16(5):R181.
   PubMed Web of Science ®Google Scholar
• Pfister D, Siegemund M, Dell-Kuster S, et al. Cerebral perfusion in sepsis-associated delirium. Crit Care. 2008;12(3):R63.
   PubMed Web of Science ®Google Scholar
• McGrane S, Girard TD, Thompson JL, et al. Procalcitonin and C-reactive protein levels at admission as predictors of duration of acute brain dysfunction in critically ill patients. Crit Care. 2011;15(2):R78.
   PubMed Web of Science ®Google Scholar
• Hughes CG, Morandi A, Girard TD, et al. Association between endothelial dysfunction and acute brain dysfunction during critical illness. Anesthesiology. 2013;118(3):631–639.
   PubMed Web of Science ®Google Scholar
• Kadoi Y, Saito S. An alteration in the gamma-aminobutyric acid receptor system in experimentally induced septic shock in rats. Crit Care Med. 1996;24(2):298–305.
   PubMed Web of Science ®Google Scholar
• Semmler A, Frisch C, Debeir T, et al. Long-term cognitive impairment, neuronal loss and reduced cortical cholinergic innervation after recovery from sepsis in a rodent model. Exp Neurol. 2007;204(2):733–740.
   PubMed Web of Science ®Google Scholar
• Jacob A, Brorson JR, Alexander JJ. Septic encephalopathy: inflammation in man and mouse. Neurochem Int. 2011;58(4):472–476.
   PubMed Web of Science ®Google Scholar
• Basler T, Meier-Hellmann A, Bredle D, et al. Amino acid imbalance early in septic encephalopathy. Intensive Care Med. 2002;28(3):293–298.
   PubMed Web of Science ®Google Scholar
• Gunther ML, Morandi A, Ely EW. Pathophysiology of delirium in the intensive care unit. Crit Care Clin. 2008;24(1):45–65.
   PubMed Web of Science ®Google Scholar
• Han L, Mccusker J, Cole M, et al. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med. 2001;161(8):1099–1105.
   PubMedGoogle Scholar
• Trzepacz PT. Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. Semin Clin Neuropsychiatry. 2000;5(2):132–148.
   PubMedGoogle Scholar
• Tsuruta R, Oda Y. A clinical perspective of sepsis-associated delirium. J Intensive Care. 2016;4:18.
   PubMed Web of Science ®Google Scholar
• Gamberini M, Bolliger D, Buse GAL, et al. Rivastigmine for the prevention of postoperative delirium in elderly patients undergoing elective cardiac surgery-a randomized controlled trial. Crit Care Med. 2009;37(5):1762–1768.
   PubMed Web of Science ®Google Scholar
• Girard TD, Ware LB, Bernard GR, et al. Associations of markers of inflammation and coagulation with delirium during critical illness. Intensive Care Med. 2012;38(12):1965–1973.
   PubMed Web of Science ®Google Scholar
• Ogino Y, Kaneda K, Nakahara T, et al. Systemic inflammation and delirium in the peri-extubation period of mechanical ventilation: an observational prospective study of intensive care unit patients. Bull Yamaguchi Med School. 2015;62:1–10.
   Google Scholar
• Tomasi CD, Vuolo F, Generoso J, et al. Biomarkers of delirium in a low-risk community-acquired pneumonia-induced sepsis. Mol Neurobiol. 2016 Jan 14.
   PubMedGoogle Scholar
• van den Boogaard M, Kox M, Quinn KL, et al. Biomarkers associated with delirium in critically ill patients and their relation with long-term subjective cognitive dysfunction; indications for different pathways governing delirium in inflamed and noninflamed patients. Crit Care. 2011;15(6):R297.
   PubMed Web of Science ®Google Scholar
• Ritter C, Tomasi CD, Dal-Pizzol F, et al. Inflammation biomarkers and delirium in critically ill patients. Crit Care. 2014;18 (3):R106.
   PubMed Web of Science ®Google Scholar
• Schwalm MT, Pasquali M, Miguel SP, et al. Acute brain inflammation and oxidative damage are related to long-term cognitive deficits and markers of neurodegeneration in sepsis-survivor rats. Mol Neurobiol. 2014;49(1):380–385.
   PubMed Web of Science ®Google Scholar
• Lemstra AW, Groen in’t Woud JC, Hoozemans JJ, et al. Microglia activation in sepsis: a case-control study. J Neuroinflammation. 2007;4:4.
   PubMed Web of Science ®Google Scholar
• Jackson AC, Gilbert JJ, Young GB, et al. The encephalopathy of sepsis. Can J Neurol Sci. 1985;12(4):303–307.
   PubMed Web of Science ®Google Scholar
• Sharshar T, Annane D, de la Grandmaison GL, et al. The neuropathology of septic shock. Brain Pathol. 2004;14 (1):21–33.
   PubMed Web of Science ®Google Scholar
• Bitsch A, Nau R, Hilgers RA, et al. Focal neurologic deficits in infective endocarditis and other septic diseases. Acta Neurol Scand. 1996;94(4):279–286.
   PubMed Web of Science ®Google Scholar
• Prange HW. Septic focal encephalitis. Intensivmed. 2006;43:85–93.
   Google Scholar
• Pruitt AA, Rubin RH, Karchmer AW, et al. Neurological complications of bacterial endocarditis. Medicine. 1978;57(4):329–343.
   PubMed Web of Science ®Google Scholar
• Tauber SC, Bunkowski S, Brück W, et al. Septic metastatic encephalitis: coexistence of brain damage and repair. Neuropathol Appl Neurobiol. 2011;37(7):768–776.
   PubMed Web of Science ®Google Scholar
• Schwechheimer K, Hashemian A. Neuropathologic findings after organ transplantation. An autopsy study. Gen Diagn Pathol. 1995;141(1):35–39.
   PubMedGoogle Scholar
• Barichello T, Martins MR, Reinke A, et al. Behavioral deficits in sepsis-surviving rats induced by cecal ligation and perforation. Braz J Med Biol Res. 2007;40(6):831–837.
   PubMed Web of Science ®Google Scholar
• Semmler A, Hermann S, Mormann F, et al. Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism. J Neuroinflammation. 2008;5:38.
   PubMed Web of Science ®Google Scholar
• Varatharaj A, Galea I. The blood-brain barrier in systemic inflammation. Brain Behav Immun. 2016. pii: S0889-1591(16)30055-1.
   PubMed Web of Science ®Google Scholar
• Morgan BP, Gasque P. Expression of complement in the brain: role in health and disease. Immunol Today. 1996;17(10):461–466.
   PubMedGoogle Scholar
• Jacob A, Hensley LK, Safratowich BD, et al. The role of the complement cascade in endotoxin-induced septic encephalopathy. Lab Invest. 2007;87(12):1186–1194.
   PubMed Web of Science ®Google Scholar
• Nadeau S, Rivest S. The complement system is an integrated part of the natural innate immune response in the brain. FASEB J. 2001;15(8):1410–1412.
   PubMed Web of Science ®Google Scholar
• Gasque P, Singhrao SK, Neal JW, et al. Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Am J Pathol. 1997;150(1):31–41.
   PubMed Web of Science ®Google Scholar
• Crane JW, Buller KM. Systemic blockade of complement C5a receptors reduces lipopolysacharride-induced responses in the paraventricular nucleus and the central amygdala. Neurosci Lett. 2007;424(1):10–15.
   PubMed Web of Science ®Google Scholar
• Flierl MA, Stahel PF, Rittirsch D, et al. Inhibition of complement C5a prevents breakdown of the blood-brain-barrier and pituitary dysfunction in experimental sepsis. Crit Care. 2009;13:R12.
   PubMed Web of Science ®Google Scholar
• Li S, Boackle SA, Holers VM, et al. Complement component c5a is integral to the febrile response of mice to lipopolysaccharide. Neuroimmunomodulation. 2005;12(2):67–80.
   PubMed Web of Science ®Google Scholar
• Mukherjee P, Thomas S, Pasinetti GM. Complement anaphylatoxin C5a neuroprotects through regulation of glutamate receptor subunit 2 in vitro and in vivo. J Neuroinflammation. 2008;5:5.
   PubMed Web of Science ®Google Scholar
• Chen Q, Yu W, Shi J, et al. Insulin alleviates the inflammatory response and oxidative stress injury in cerebral tissues in septic rats. J Inflamm. 2014;11:18.
   Google Scholar
• Barichello T, Machado RA, Constantino L, et al. Antioxidant treatment prevented late memory impairment in an animal model of sepsis. Crit Care Med. 2007;35(9):2186–2190.
   PubMed Web of Science ®Google Scholar
• Toklu HZ, Uysal MK, Kabasakal L, et al. The effects of riluzole on neurological, brain biochemical, and histological changes in early and late term of sepsis in rats. J Surg Res. 2009;152(2):238–248.
   PubMed Web of Science ®Google Scholar
• Vincent JL, Privalle CT, Singer M, et al. Multicenter, randomized, placebo-controlled phase III study of pyridoxalated hemoglobin polyoxyethylene in distributive shock (PHOENIX). Crit Care Med. 2015;43(1):57–64.
   PubMed Web of Science ®Google Scholar
• Grover R, Zaccardelli D, Colice G, et al. An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome international septic shock study group. Crit Care Med. 1999;27(5):913–922.
   PubMed Web of Science ®Google Scholar
• Lopez A, Lorente JA, Steingrub J, et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med. 2004;32(1):21–30.
   PubMed Web of Science ®Google Scholar
• Rice TW, Wheeler AP, Bernard GR, et al. A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit Care Med. 2010;38(8):1685–1694.
   PubMed Web of Science ®Google Scholar
• Albertson TE, Panacek EA, MacArthur RD, et al. Multicenter evaluation of a human monoclonal antibody to Enterobacteriaceae common antigen in patients with gram-negative sepsis. Crit Care Med. 2003;31(2):419–427.
   PubMed Web of Science ®Google Scholar
• Root RK, Lodato RF, Patrick W, et al. Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis. Crit Care Med. 2003;31(2):367–373.
   PubMed Web of Science ®Google Scholar
• McCloskey RV, Straube RC, Sanders C, et al. Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS trial study group. Ann Intern Med. 1994;121(1):1–5.
   PubMed Web of Science ®Google Scholar
• Angus DC, Birmingham MC, Balk RA, et al. E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. E5 study investigators. JAMA. 2000;283(13):1723–1730.
   PubMed Web of Science ®Google Scholar
• Abraham E, Wunderink R, Silverman H, et al. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. Tnf-alpha mab sepsis study group. JAMA. 1995;273(12):934–941.
   PubMed Web of Science ®Google Scholar
• Cohen J, Carlet J. INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International sepsis trial study group. Crit Care Med. 1996;24(9):1431–1440.
   PubMed Web of Science ®Google Scholar
• Abraham E, Anzueto A, Gutierrez G, et al. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II study group. Lancet. 1998;351(9107):929–933.
   PubMed Web of Science ®Google Scholar
• Opal SM, Fisher CJ Jr, Dhainaut JF, et al. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The interleukin-1 receptor antagonist sepsis investigator group. Crit Care Med. 1997;25(7):1115–1124.
   PubMed Web of Science ®Google Scholar
• Ferrer R, Martin-Loeches I, Phillips G, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014;42(8):1749–1755.
   PubMed Web of Science ®Google Scholar
• Volbeda M, Wetterslev J, Gluud C, et al. Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis. Intensive Care Med. 2015;41(7):1220–1234.
   PubMed Web of Science ®Google Scholar
• Keh D, Trips E, Marx G, et al. Effect of hydrocortisone on development of shock among patients with severe sepsis: the HYPRESS randomized clinical trial. JAMA. 2016;316(17):1775–1785.
   PubMed Web of Science ®Google Scholar
• COIITSS Study Investigators, Annane D, Cariou A, et al. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA 2010; 303 (4):341–348.
   PubMed Web of Science ®Google Scholar
• Annane D, Bellissant E, Bollaert PE, et al. Corticosteroids for treating sepsis. Cochrane Database Syst Rev. 2015;(12):CD002243.
   Google Scholar
• Póvoa P, Salluh JI, Martinez ML, et al. Clinical impact of stress dose steroids in patients with septic shock: insights from the PROWESS-shock trial. Crit Care. 2015;19:193.
   PubMed Web of Science ®Google Scholar
• Arabi YM, Aljumah A, Dabbagh O, et al. Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial. CMAJ. 2010;182(18):1971–1977.
   PubMed Web of Science ®Google Scholar
• Kress JP. Clinical trials of early mobilization of critically ill patients. Crit Care Med. 2009;37(10 Suppl):S442–S447.
   PubMedGoogle Scholar
• Schweickert WD, Pohlman MC, Pohlman AS, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet. 2009;373(9678):1874–1882.
   PubMed Web of Science ®Google Scholar
• Page VJ, Davis D, Zhao XB, et al. Statin use and risk of delirium in the critically ill. Am J Respir Crit Care Med. 2014;189(6):666–673.
   PubMed Web of Science ®Google Scholar
• Morandi A, Hughes CG, Thompson JL, et al. Statins and delirium during critical illness: a multicenter, prospective cohort study. Crit Care Med. 2014;42 (8):1899–1909.
   PubMed Web of Science ®Google Scholar
• Needham DM, Colantuoni E, Dinglas VD, et al. Rosuvastatin versus placebo for delirium in intensive care and subsequent cognitive impairment in patients with sepsis-associated acute respiratory distress syndrome: an ancillary study to a randomised controlled trial. Lancet Respir Med. 2016;4(3):203–212.
   PubMed Web of Science ®Google Scholar
• Dinglas VD, Hopkins RO, Wozniak AW, et al. One-year outcomes of rosuvastatin versus placebo in sepsis-associated acute respiratory distress syndrome: prospective follow-up of SAILS randomised trial. Thorax. 2016;71(5):401–410.
   PubMed Web of Science ®Google Scholar
• Casarin A, McAuley DF, Alce TM, et al. Evaluating early administration of the hydroxymethylglutaryl-CoA reductase inhibitor simvastatin in the prevention and treatment of delirium in critically ill ventilated patients (MoDUS trial): study protocol for a randomized controlled trial. Trials. 2015;16:218.
   PubMed Web of Science ®Google Scholar
• Gao R, Tang YH, Tong JH, et al. Systemic lipopolysaccharide administration-induced cognitive impairments are reversed by erythropoietin treatment in mice. Inflammation. 2015;38(5):1949–1958.
   PubMed Web of Science ®Google Scholar
• Li R, Tong J, Tan Y, et al. Low molecular weight heparin prevents lipopolysaccharide induced-hippocampus-dependent cognitive impairments in mice. Int J Clin Exp Pathol. 2015;8(8):8881–8891.
   PubMed Web of Science ®Google Scholar
• Zhu SZ, Huang WP, Huang LQ, et al. Huperzine A protects sepsis associated encephalopathy by promoting the deficient cholinergic nervous function. Neurosci Lett. 2016;631:70–78.
   PubMed Web of Science ®Google Scholar
• Gao R, Kan MQ, Wang SG, et al. Disrupted tryptophan metabolism induced cognitive impairment in a mouse model of sepsis-associated encephalopathy. Inflammation. 2016;39 (2):550–560.
   PubMed Web of Science ®Google Scholar
• Imamura Y, Wang H, Matsumoto N, et al. Interleukin-1β causes long-term potentiation deficiency in a mouse model of septic encephalopathy. Neuroscience. 2011;187:63–69.
   PubMed Web of Science ®Google Scholar
• Sui D-M, Xie Q, Yi W-J, et al. Resveratrol protects against sepsis-associated encephalopathy and inhibits the NLRP3/IL-1β axis in microglia. Mediators Inflamm. 2016;2016:1–10.
   Web of Science ®Google Scholar
• Ritter C, Andrades M, Frota Júnior ML, et al. Oxidative parameters and mortality in sepsis induced by cecal ligation and perforation. Intensive Care Med. 2003;29(10):1782–1789.
   PubMed Web of Science ®Google Scholar
• Michels M, Danieslki LG, Vieira A, et al. CD40-CD40 ligand pathway is a major component of acute neuroinflammation and contributes to long-term cognitive dysfunction after sepsis. Mol Med. 2015;21:219–226.
   PubMed Web of Science ®Google Scholar
• Wilson JX, Wu F. Vitamin C in sepsis. Subcell Biochem. 2012;56:67–83.
   PubMedGoogle Scholar
• Yokoo H, Chiba S, Tomita K, et al. Neurodegenerative evidence in mice brains with cecal ligation and puncture-induced sepsis: preventive effect of the free radical scavenger edaravone. PLoS One. 2012;7(12):e51539.
   PubMed Web of Science ®Google Scholar
• Hernandes MS, D’Avila JC, Trevelin SC, et al. The role of Nox2-derived ROS in the development of cognitive impairment after sepsis. J Neuroinflammation. 2014;11:36.
   PubMed Web of Science ®Google Scholar
• Zhou TF, Yu JG. Recombinant human erythropoietin attenuates neuronal apoptosis and cognitive defects via JAK2/STAT3 signaling in experimental endotoxemia. J Surg Res. 2013;183(1):304–312.
   PubMed Web of Science ®Google Scholar
• Wang GB, Ni YL, Zhou XP, et al. The AKT/mTOR pathway mediates neuronal protective effects of erythropoietin in sepsis. Mol Cell Biochem. 2014;385(1–2):125–132.
   PubMed Web of Science ®Google Scholar
• Michels M, Vieira AS, Vuolo F, et al. The role of microglia activation in the development of sepsis-induced long-term cognitive impairment. Brain Behav Immun. 2014;43:54–59.
   PubMed Web of Science ®Google Scholar
• Wu J, Zhang M, Hao S, et al. Mitochondria-targeted peptide reverses mitochondrial dysfunction and cognitive deficits in sepsis-associated encephalopathy. Mol Neurobiol. 2015;52 (1):783–791.
   PubMed Web of Science ®Google Scholar
• Huang M, Liu C, Hu Y, et al. Gamma-secretase inhibitor DAPT prevents neuronal death and memory impairment in sepsis associated encephalopathy in septic rats. Chin Med J (Engl). 2014;127(5):924–928.
   PubMed Web of Science ®Google Scholar
• Fang J, Lian Y, Xie K, et al. Epigenetic modulation of neuronal apoptosis and cognitive functions in sepsis-associated encephalopathy. Neurol Sci. 2014;35(2):283–288.
   PubMed Web of Science ®Google Scholar
• Wu J, Dong L, Zhang M, et al. Class I histone deacetylase inhibitor valproic acid reverses cognitive deficits in a mouse model of septic encephalopathy. Neurochem Res. 2013;38(11):2440–2449.
   PubMed Web of Science ®Google Scholar
• Esen F, Erdem T, Aktan D, et al. Effect of magnesium sulfate administration on blood-brain barrier in a rat model of intraperitoneal sepsis: a randomized controlled experimental study. Crit Care. 2005;9(1):R18–R23.
   Google Scholar
• Spapen H, Nguyen DN, Troubleyn J, et al. Drotrecogin alfa (activated) may attenuate severe sepsis-associated encephalopathy in clinical septic shock. Crit Care. 2010;14(2):R54.
   Google Scholar
• Mussack T, Briegel J, Schelling G, et al. Effect of stress doses of hydrocortisone on S-100B vs. interleukin-8 and polymorphonuclear elastase levels in human septic shock. Clin Chem Lab Med. 2005;43(3):259–268.
   PubMed Web of Science ®Google Scholar
• Mussack T, Briegel J, Schelling G, et al. Hemofiltration does not influence early S-100B serum levels in septic shock patients receiving stress doses of hydrocortisone or placebo. Eur J Med Res. 2005;10(2):81–87.
   PubMed Web of Science ®Google Scholar
• Nau R, Djukic M, Spreer A, et al. Bacterial meningitis: an update of new treatment options. Expert Rev Anti Infect Ther. 2015;13(11):1401–1423.
   PubMed Web of Science ®Google Scholar
• Mascalchi M, Vella A. Magnetic resonance and nuclear medicine imaging in ataxias. Handb Clin Neurol. 2012;103:85–110.
   PubMedGoogle Scholar
• Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome. Med Klin Intensivmed Notfmed. 2016;111(5):417–424.
   PubMed Web of Science ®Google Scholar
• Albrecht DS, Granziera C, Hooker JM, et al. In vivo imaging of human neuroinflammation. ACS Chem Neurosci. 2016;7 (4):470–483.
   PubMed Web of Science ®Google Scholar
• Adam N, Kandelman S, Mantz J, et al. Sepsis-induced brain dysfunction. Expert Rev Anti Infect Ther. 2013;11(2):211–221.
   PubMed Web of Science ®Google Scholar